{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:04Z","timestamp":1772119264686,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00280-024-04727-8","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T01:02:09Z","timestamp":1735174929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetics of cisplatin in the systemic versus hyperthermic intrathoracic or intraperitoneal chemotherapy"],"prefix":"10.1007","volume":"95","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-gong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"3","key":"4727_CR1","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.3747\/co.23.2831","volume":"23","author":"J Spiliotis","year":"2016","unstructured":"Spiliotis J, Halkia E, de Bree E (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol 23(3):e266-75","journal-title":"Curr Oncol"},{"issue":"4","key":"4727_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s13304-020-00788-5","volume":"72","author":"A Di Leo","year":"2020","unstructured":"Di Leo A et al (2020) Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study. Updates Surg 72(4):1207\u20131212","journal-title":"Updates Surg"},{"key":"4727_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.suronc.2019.09.002","volume":"31","author":"MC Morris","year":"2019","unstructured":"Morris MC et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) for patients at high-risk of peritoneal metastases. Surg Oncol 31:33\u201337","journal-title":"Surg Oncol"},{"issue":"4","key":"4727_CR4","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.21873\/invivo.12008","volume":"34","author":"P Faviana","year":"2020","unstructured":"Faviana P et al (2020) Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center. In Vivo 34(4):2061\u20132066","journal-title":"In Vivo"},{"issue":"1","key":"4727_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12957-020-01956-y","volume":"18","author":"J Jiao","year":"2020","unstructured":"Jiao J et al (2020) Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites. World J Surg Oncol 18(1):180","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4727_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/a-0934-7806","volume":"145","author":"M Ried","year":"2020","unstructured":"Ried M et al (2020) Expert recommendation for the implementation of hyperthermic intrathoracic chemotherapy (HITOC) in Germany. Zentralbl Chir 145(1):89\u201398","journal-title":"Zentralbl Chir"},{"issue":"30","key":"4727_CR7","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.3748\/wjg.v22.i30.6906","volume":"22","author":"Y Li","year":"2016","unstructured":"Li Y et al (2016) Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 22(30):6906\u201316","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4727_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1245\/s10434-013-3061-z","volume":"21","author":"K Turaga","year":"2014","unstructured":"Turaga K et al (2014) Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol 21(5):1501\u20135","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4727_CR9","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1111\/ajco.12723","volume":"14","author":"EYT Wong","year":"2018","unstructured":"Wong EYT et al (2018) Morbidity and mortality of elderly patients following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Asia Pac J Clin Oncol 14(2):e193\u2013e202","journal-title":"Asia Pac J Clin Oncol"},{"issue":"9","key":"4727_CR10","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/jog.14391","volume":"46","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi H et al (2020) Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res 46(9):1661\u20131671","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"4727_CR11","first-page":"299","volume":"63","author":"C Lu","year":"2016","unstructured":"Lu C et al (2016) Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites. Neoplasma 63(2):299\u2013303","journal-title":"Neoplasma"},{"issue":"16","key":"4727_CR12","doi-asserted-by":"publisher","first-page":"21570","DOI":"10.18632\/oncotarget.7622","volume":"7","author":"L Liu","year":"2016","unstructured":"Liu L et al (2016) Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC). Oncotarget 7(16):21570\u20138","journal-title":"Oncotarget"},{"issue":"1","key":"4727_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/02656736.2022.2028018","volume":"39","author":"L Liu","year":"2022","unstructured":"Liu L et al (2022) A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer. Int J Hyperthermia 39(1):239\u2013245","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"4727_CR14","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1245\/s10434-009-0878-6","volume":"19","author":"WP Ceelen","year":"2012","unstructured":"Ceelen WP et al (2012) Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer. Ann Surg Oncol 19(7):2352\u20139","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"4727_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jso.20243","volume":"90","author":"TW Reichman","year":"2005","unstructured":"Reichman TW et al (2005) Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma. J Surg Oncol 90(2):51\u20136","journal-title":"J Surg Oncol"},{"issue":"5","key":"4727_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00423-014-1207-5","volume":"399","author":"I Konigsrainer","year":"2014","unstructured":"Konigsrainer I et al (2014) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience. Langenbecks Arch Surg 399(5):589\u201394","journal-title":"Langenbecks Arch Surg"},{"issue":"1","key":"4727_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0091270009360980","volume":"51","author":"E Cotte","year":"2011","unstructured":"Cotte E et al (2011) Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure. J Clin Pharmacol 51(1):9\u201318","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"4727_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/bjc.2014.602","volume":"112","author":"L Ansaloni","year":"2015","unstructured":"Ansaloni L et al (2015) Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer. Br J Cancer 112(2):306\u201312","journal-title":"Br J Cancer"},{"issue":"3","key":"4727_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/ijc.29011","volume":"136","author":"O Zivanovic","year":"2015","unstructured":"Zivanovic O et al (2015) HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. Int J Cancer 136(3):699\u2013708","journal-title":"Int J Cancer"},{"issue":"3","key":"4727_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378(3):230\u2013240","journal-title":"N Engl J Med"},{"issue":"2","key":"4727_CR21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1378\/chest.121.2.480","volume":"121","author":"E de Bree","year":"2002","unstructured":"de Bree E et al (2002) Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma. Chest 121(2):480\u20137","journal-title":"Chest"},{"issue":"18","key":"4727_CR22","doi-asserted-by":"publisher","first-page":"4580","DOI":"10.3390\/cancers13184580","volume":"13","author":"M Ried","year":"2021","unstructured":"Ried M et al (2021) Hyperthermic intrathoracic chemotherapy (HITOC) after cytoreductive surgery for pleural malignancies\u2014a retrospective, multicentre study. Cancers (Basel) 13(18):4580","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4727_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ejcts\/ezv039","volume":"49","author":"MC Ambrogi","year":"2016","unstructured":"Ambrogi MC et al (2016) Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapydagger. Eur J Cardiothorac Surg 49(1):321\u20136","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"4727_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00228-012-1405-4","volume":"69","author":"PH Cashin","year":"2013","unstructured":"Cashin PH et al (2013) Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur J Clin Pharmacol 69(3):533\u201340","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"4727_CR25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jso.23321","volume":"107","author":"M Ried","year":"2013","unstructured":"Ried M et al (2013) Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies. J Surg Oncol 107(7):735\u201340","journal-title":"J Surg Oncol"},{"issue":"4","key":"4727_CR26","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e59","volume":"30","author":"M Petrillo","year":"2019","unstructured":"Petrillo M et al (2019) Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study. J Gynecol Oncol 30(4):e59","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"4727_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1245\/s10434-007-9571-9","volume":"15","author":"A Gesson-Paute","year":"2008","unstructured":"Gesson-Paute A et al (2008) Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 15(1):339\u201344","journal-title":"Ann Surg Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-024-04727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-024-04727-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-024-04727-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T01:03:06Z","timestamp":1735174986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-024-04727-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1007\/s00280-024-04727-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4427284\/v1","asserted-by":"object"}]},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical experiment was approved by the Local Ethical Review Committee (Assigned No. 202103\u201329; Shaanxi, China).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13"}}